Beddow Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $540K | Hold |
4,465
| – | – | 0.21% | 39 |
|
|
2025
Q1 | $498K | Sell |
4,465
-125
| -3% | -$13.9K | 0.19% | 40 |
|
|
2024
Q4 | $447K | Buy |
4,590
+1,350
| +42% | +$131K | 0.18% | 45 |
|
|
2024
Q3 | $373K | Hold |
3,240
| – | – | 0.15% | 50 |
|
|
2024
Q2 | $345K | Hold |
3,240
| – | – | 0.15% | 51 |
|
|
2024
Q1 | $313K | Sell |
3,240
-1,000
| -24% | -$96.6K | 0.14% | 53 |
|
|
2023
Q4 | $428K | Hold |
4,240
| – | – | 0.2% | 43 |
|
|
2023
Q3 | $432K | Hold |
4,240
| – | – | 0.21% | 43 |
|
|
2023
Q2 | $428K | Hold |
4,240
| – | – | 0.22% | 44 |
|
|
2023
Q1 | $390K | Sell |
4,240
-1,125
| -21% | -$103K | 0.2% | 42 |
|
|
2022
Q4 | $487K | Hold |
5,365
| – | – | 0.25% | 38 |
|
|
2022
Q3 | $408K | Sell |
5,365
-250
| -4% | -$19K | 0.25% | 41 |
|
|
2022
Q2 | $475K | Buy |
5,615
+315
| +6% | +$26.6K | 0.28% | 40 |
|
|
2022
Q1 | $465K | Buy |
+5,300
| New | +$465K | 0.25% | 43 |
|